Category
Neurocritical Care & Cardiac Arrest
Journal
Lancet
Takeaway
rFVIIa for ICH stopped early: reduced bleeding, no functional benefit, tripled thromboembolic events.
Verdict
Harm Signal
Year
2026
Lancet
rFVIIa for ICH stopped early: reduced bleeding, no functional benefit, tripled thromboembolic events.